首页> 美国卫生研究院文献>PLoS Clinical Trials >A Multicenter Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer

【2h】

A Multicenter Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer

机译：多中心紫杉醇方案联合泼尼松与米托蒽醌联合泼尼松治疗中国去势难治性前列腺癌患者的多中心随机临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo explore the feasibility and efficacy of docetaxel plus prednisone for Chinese population with metastatic castration refractory prostate cancer (mCRPC).

机译：目的探讨多西他赛联合泼尼松在中国人群去势难治性前列腺癌（mCRPC）中的可行性和有效性。

著录项

期刊名称 PLoS Clinical Trials
作者
Tie Zhou; Shu-xiong Zeng; Ding-wei Ye; Qiang Wei; Xu Zhang; Yi-ran Huang; Zhang-qun Ye; Yong Yang; Wei Zhang; Ye Tian; Fang-jian Zhou; Jin Jie; Shi-ping Chen; Yan Sun; Li-ping Xie; Xing Yao; Yan-qun Na; Ying-hao Sun;
展开▼
作者单位

展开▼
年(卷),期 2015(10),1
年度 2015
页码 e0117002
总页数 13
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5 [J] . Fizazi Karim, Jones Robert, Oudard Stephane, Journal of Clinical Oncology . 2015,第7期

机译：多西他赛治疗期间或之后进展为转移性去势抵抗的前列腺癌患者的三期随机双盲多中心试验，比较Orteronel（TAK-700）+泼尼松与安慰剂+泼尼松
2. Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5 [J] . Fizazi Karim, Jones Robert, Oudard Stephane, Journal of Clinical Oncology . 2015,第7期

机译：III期，随机，双盲，多中心试验比较ORTERONEL（TAK-700）加上安慰剂加上泼尼松的转移性阉割抗阉割前列腺癌患者，这些前列腺癌在基于多西紫杉醇的治疗期间或之后进行：ELM-PC 5
3. Re: Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) plus Prednisone with Placebo plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer that has Progressed during or after Docetaxel-Based Therapy: ELM-PC 5 Editorial Comment [J] . Taneja Samir S. The Journal of Urology . 2015,第4期

机译：回复：在基于多西他赛的治疗期间或之后进展为转移性去势抵抗的前列腺癌患者中，III期，双盲，多盲，多中心试验比较了Orteronel（TAK-700）+泼尼松与安慰剂+泼尼松的进展社论评论
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Evaluation of a randomized clinical trial of a psychoeducational intervention on long-term quality of life, negative affect, progression and survival in head and neck cancer patients. [D] . Trevino, Lara A. 2011

机译：心理教育干预对头颈部癌症患者的长期生活质量，负面影响，进展和生存的随机临床试验评估。
6. Phase III Randomized Double-Blind Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5 [O] . Karim Fizazi, Robert Jones, Stephane Oudard, -1

机译：多西他赛治疗期间或之后进展为转移性去势抵抗的前列腺癌患者的三期随机双盲多中心试验比较Orteronel（TAK-700）+泼尼松与安慰剂+泼尼松
7. A multicenter, randomized clinical trial comparing the three-weekly docetaxel regimen plus prednisone versus mitoxantone plus prednisone for Chinese patients with metastatic castration refractory prostate cancer. [O] . Tie Zhou, Shu-xiong Zeng, Ding-wei Ye, 2015

机译：一项多中心，随机临床试验，比较三周多西紫杉醇方案加泼尼松与米托蒽醌加泼尼松治疗中国转移性阉割难治性前列腺癌患者。

A Multicenter Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer

摘要

著录项

相似文献

相关主题

期刊订阅